Busta Rhymes was set to embark on a 24-date Blockbusta tour, but it has been cancelled based on updates on Ticketmaster.com.
Every concert, from the March 13 opener in San Francisco to the April 21 closing show in the rapper's hometown of Brooklyn, is listed as cancelled on the concert ticketing site.
USA TODAY has reached out to Rhymes' reps and Live Nation, which announced the tour in November 2023.
Previously, Rhymes had been on 50 Cent's The Final Lap tour, which ended in December. Before heading out on that tour, Rhymes detailed in Men's Health magazine how he had lost 100 pounds to improve his health after suffering what he described as "felt like I was having like an asthma attack – but I don’t have asthma."
Sea.Hear.Now festival:Bruce Springsteen & the E Street Band, Noah Kahan to headline
He lost more weight while touring with 50 Cent, Rhymes said in November 2023 while promoting the release of his "Blockbusta" album, Complex reported.
The multiplatinum rapper, songwriter and record producer – known for songs such as “Put Your Hands Where My Eyes Could See” and "Woo-Hah!! Got You All in Check" – had been honored at the BET Awards in June 2023 with a lifetime achievement award. Late last month, he performed at a joint The Recording Industry Association of America (RIAA) and Spotify event benefiting Musicians On Call (MOC) at newly opened venue The Atlantis in Washington DC.
If you are holding tickets to Rhymes' tour, there should be an update coming from Ticketmaster about rescheduled dates or refunds.
Follow Mike Snider on X and Threads: @mikesnider & mikegsnider.
What's everyone talking about? Sign up for our trending newsletter to get the latest news of the day
2024-12-26 11:261074 view
2024-12-26 11:06406 view
2024-12-26 11:001909 view
2024-12-26 10:121411 view
2024-12-26 10:091819 view
2024-12-26 09:542895 view
The digital parking payment app ParkMobile has agreed to a $32.8 million settlement after a 2021 dat
OceanGate CEO Stockton Rush, the owner and pilot of the doomed Titan sub, had offered millionaire Ja
The first drug shown to slow down Alzheimer's disease is likely to receive full approval from the Fo